HbA1c (Glycated Hemoglobin) - Biochemistry

1. What Is HbA1c?

HbA1c is a specific fraction of adult hemoglobin A (HbA) in which glucose has formed a stable, covalent adduct at the N-terminal valine of the beta (β) chain. It belongs to a broader family of glycated hemoglobins (HbA1), which also includes HbA1a1, HbA1a2, and HbA1b (see table below).

Fraction	Adduct Attached
HbA1a1	Fructose-1,6-diphosphate at β-chain N-terminal valine
HbA1a2	Glucose-6-phosphate at β-chain N-terminal valine
HbA1b	Pyruvic acid at β-chain N-terminal valine
HbA1c	Glucose at β-chain N-terminal valine
Pre-HbA1c	Unstable Schiff base (labile intermediate)

Source: Tietz Textbook of Laboratory Medicine, 7th Ed.

2. Mechanism of Formation (Glycation Reaction)

The formation of HbA1c is a non-enzymatic, irreversible two-step process - part of the broader Maillard/Amadori chemistry:

Formation of HbA1c showing the two-step reaction from HbA + Glucose to pre-HbA1c (Schiff base/aldimine) to stable HbA1c (ketoamine) via Amadori rearrangement

Step 1 - Rapid and Reversible: The aldehyde group of glucose condenses with the free amino group (ε-amino of lysyl residues or the α-amino group of the N-terminal valine of β-chains) to form an unstable Schiff base (aldimine) called pre-HbA1c. This reaction is rapid and reversible.

Step 2 - Slow and Irreversible: The Schiff base undergoes an Amadori rearrangement to yield a stable ketoamine - this is the true HbA1c. This second step is slow and essentially irreversible under physiological conditions.

Key point: Glycation (non-enzymatic) is distinct from glycosylation (enzyme-catalyzed addition of sugar moieties to proteins). - Harper's Illustrated Biochemistry, 32nd Ed.

3. Why Does It Reflect Long-Term Glucose Control?

Erythrocyte lifespan is approximately 120 days
HbA1c accumulates gradually over the RBC lifespan - the rate of formation is proportional to ambient blood glucose
HbA1c concentration therefore reflects the mean blood glucose over the preceding 8-12 weeks
The glycation rate is highest in the first 2 months, followed by more gradual change approaching steady state at ~3 months
Normally, about 5% of hemoglobin is glycated in healthy individuals

4. Labile Fraction (Pre-HbA1c) - Clinical Pitfall

Pre-HbA1c (the Schiff base intermediate) amounts to 5-8% of total HbA1 in healthy individuals and 8-30% in diabetics
It changes rapidly with acute glucose fluctuations and does NOT reflect long-term control
Some assay methods (especially older ion-exchange methods) inadvertently include the labile fraction, causing falsely elevated results
The labile fraction can be removed by incubating washed red blood cells in saline (in the absence of glucose, it reverts back to glucose + HbA)
Boronate affinity methods promote rapid dissociation of the Schiff base, minimizing this problem

5. Clinical Utility

Diagnosis of Diabetes

Since 2010, HbA1c has been accepted as a diagnostic criterion for diabetes:

≥6.5% = Diabetes mellitus
5.7% - 6.4% = Prediabetes
<5.7% = Normal

Advantages of HbA1c over plasma glucose testing:

Fasting is NOT required
Very low biological variability
Sample is stable
Predicts risk of microvascular complications

Source: Robbins & Kumar Basic Pathology; Tietz Textbook of Laboratory Medicine, 7th Ed.

Monitoring Diabetes

Target for most diabetics: <6.5 to 7% (48-53 mmol/mol) per major diabetes organizations
Each 1% reduction in HbA1c is associated with:
- 37% reduction in risk of microvascular disease
- 21% reduction in diabetes-related death
- 14% reduction in myocardial infarction (UKPDS trial data)
There is no HbA1c concentration below which microvascular risk is eliminated - risk varies exponentially

6. Measurement Methods

Over 250 methods have been described. They broadly fall into two categories:

Charge-based separation:

Ion-exchange chromatography (HPLC) - most common; susceptible to labile fraction interference
Electrophoresis
Isoelectric focusing
Capillary electrophoresis

Structure-based separation:

Boronate affinity chromatography - least affected by Hb variants
Immunoassay

Chemical/enzymatic analysis:

Enzymatic assay (specifically measures HbA1c)

Results are expressed as a fraction (%) of total hemoglobin. The NGSP (National Glycohemoglobin Standardization Program) certifies assay methods traceable to the DCCT reference, ensuring comparability of results across labs. The IFCC reference method uses endoproteinase Glu-C digestion followed by HPLC-ESI-MS or capillary electrophoresis of the glycated N-terminal hexapeptide of the β-chain.

7. Test Limitations and Interferences

HbA1c is only valid when RBC lifespan is normal. False results occur in:

Cause	Effect on HbA1c
Hemolytic anemia	Falsely LOW (shortened RBC lifespan)
Recent blood transfusion	Falsely LOW (dilution with non-glycated donor RBCs)
Recent significant blood loss	Falsely LOW (higher fraction of young erythrocytes)
Iron deficiency anemia	Falsely HIGH (older RBCs accumulate more glycation)
Hemoglobin variants (HbS, HbC, HbF)	Results can be spuriously increased or decreased - depends on assay method
Labile pre-HbA1c not removed	Falsely HIGH

Boronate affinity methods are minimally affected by Hb variants
HPLC and capillary electrophoresis chromatograms can visually flag the presence of variant hemoglobins
Point-of-care HbA1c devices should not be used for screening or diagnosis of diabetes

Summary

Feature	Detail
Type of modification	Non-enzymatic glycation (not glycosylation)
Primary site	α-amino group of N-terminal valine, β-chains of HbA
Intermediate	Pre-HbA1c (Schiff base/aldimine) - labile
Stable product	HbA1c (ketoamine) via Amadori rearrangement
Reflects glucose over	8-12 weeks (RBC lifespan ~120 days)
Normal fraction	~5% of total hemoglobin
Diagnostic cut-off	≥6.5% for diabetes; 5.7-6.4% for prediabetes
Gold standard assay	NGSP-certified HPLC

Sources: Harper's Illustrated Biochemistry (32nd Ed.), Tietz Textbook of Laboratory Medicine (7th Ed.), Robbins & Kumar Basic Pathology

This is a shared conversation. Sign in to Orris to start your own chat.